It is commonly requested by women post-GLP-1 treatment
Randomized Clin Trial Diabetes Care 41(2):258266 Ahrn B, Masmiquel L, Kumar H, Sargin M, Karsbl JD, Jacobsen SH, Chow F (2017) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
The Regulatory Framework: 503A and 503B Compounding Before examining the medications themselves, understanding the legal framework governing pharmaceutical compounding is essential
Lets say you have a BCBS plan that covers Trulicity as a tier 2 drug with a 10% coinsurance